Profile | GDS4284 / 200983_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1521.65 | 80 |
GSM687648 | Patient 402 control | 1712.65 | 81 |
GSM687653 | Patient 403 control | 1185.52 | 77 |
GSM687658 | Patient 404 control | 1116.6 | 76 |
GSM687663 | Patient 411 control | 1435.44 | 79 |
GSM687668 | Patient 422 control | 1279.12 | 77 |
GSM687673 | Patient 424 control | 1544.29 | 80 |
GSM687678 | Patient 425 control | 2075.3 | 84 |
GSM687683 | Patient 427 control | 1982.95 | 84 |
GSM687688 | Patient 428 control | 849.898 | 72 |
GSM687695 | Patient 441 control | 3965.76 | 92 |
GSM687699 | Patient 443 control | 1385.78 | 79 |
GSM687704 | Patient 444 control | 1082.13 | 75 |
GSM687707 | Patient 448 control | 1035.3 | 75 |
GSM687712 | Patient 449 control | 1353.76 | 79 |
GSM687719 | Patient 450 control | 2113.07 | 85 |
GSM687724 | Patient 451 control | 1437.2 | 80 |
GSM687728 | Patient 452 control | 1510.88 | 80 |
GSM687646 | Patient 401 treated 24h | 1807.56 | 82 |
GSM687649 | Patient 402 treated 24h | 2008.12 | 84 |
GSM687665 | Patient 411 treated 24h | 1436 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 1816.46 | 82 |
GSM687667 | Patient 411 treated 4 weeks | 922.909 | 72 |
GSM687670 | Patient 422 treated 24h | 1400.54 | 79 |
GSM687671 | Patient 422 treated 4 weeks | 1307.31 | 78 |
GSM687654 | Patient 403 treated 24h | 1063.55 | 75 |
GSM687675 | Patient 424 treated 24h | 1638.27 | 81 |
GSM687685 | Patient 427 treated 24h | 1700.3 | 82 |
GSM687656 | Patient 403 treated 4 weeks | 907.628 | 73 |
GSM687677 | Patient 424 treated 4 weeks | 798.319 | 70 |
GSM687687 | Patient 427 treated 4 weeks | 1511.02 | 80 |
GSM687692 | Patient 428 treated 4h | 988.888 | 74 |
GSM687716 | Patient 449 treated 4h | 1143.65 | 76 |
GSM687722 | Patient 450 treated 4h | 2469.99 | 87 |
GSM687680 | Patient 425 treated 24h | 2153.98 | 85 |
GSM687690 | Patient 428 treated 24h | 897.576 | 73 |
GSM687700 | Patient 443 treated 24h | 2824.93 | 89 |
GSM687705 | Patient 444 treated 24h | 2357.24 | 86 |
GSM687714 | Patient 449 treated 24h | 1524.15 | 80 |
GSM687721 | Patient 450 treated 24h | 4512.75 | 93 |
GSM687682 | Patient 425 treated 4 weeks | 1847.35 | 83 |
GSM687694 | Patient 428 treated 4 weeks | 1151.01 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 1526.38 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 1139.76 | 76 |
GSM687723 | Patient 450 treated 4 weeks | 1773.25 | 82 |
GSM687661 | Patient 404 treated 4h | 1585.03 | 81 |
GSM687710 | Patient 448 treated 4h | 963.556 | 74 |
GSM687726 | Patient 451 treated 4h | 1513.84 | 80 |
GSM687730 | Patient 452 treated 4h | 1026.87 | 74 |
GSM687660 | Patient 404 treated 24h | 10669.3 | 97 |
GSM687697 | Patient 441 treated 24h | 2733.52 | 88 |
GSM687709 | Patient 448 treated 24h | 1245.42 | 78 |
GSM687725 | Patient 451 treated 24h | 2308.43 | 86 |
GSM687729 | Patient 452 treated 24h | 4457.53 | 93 |
GSM687727 | Patient 451 treated 4 weeks | 1228.15 | 77 |
GSM687731 | Patient 452 treated 4 weeks | 1408.73 | 79 |